Literature DB >> 3865177

Expression of hepatitis B surface antigen with a recombinant adenovirus.

A R Davis, B Kostek, B B Mason, C L Hsiao, J Morin, S K Dheer, P P Hung.   

Abstract

Early region 1 of the adenovirus type 5 genome was replaced with a DNA sequence containing the gene coding for the hepatitis B surface antigen (HBsAg) flanked by the major late promoter from adenovirus 2 and processing and polyadenylylation signals from simian virus 40. In one type of hybrid virus only the adenovirus 2 major late promoter, including just 33 base pairs of the adenovirus type 2 tripartite leader, preceded the coding region of the HBsAg gene. In another, this region was preceded by both the adenovirus major late promoter and almost the entire tripartite leader. The structure of the substituted sequence in each of the recombinant viral DNAs was identical to that in the plasmids used to construct the viruses. Approximately equivalent amounts of HBsAg-specific mRNA were produced late in infection with each recombinant virus. Although HBsAg production was detected late in infection of the hybrid virus not containing the full tripartite leader sequence, its level was 1/70th of that obtained with the hybrid virus containing this sequence. One likely interpretation is that the presence of the tripartite leader at the 5' end of this mRNA is critical for the synthesis of HBsAg polypeptide in the late stage of infection. HBsAg produced upon infection with the hybrid adenoviruses was glycosylated and secreted into the culture medium as particles that were essentially indistinguishable from the 22-nm particles found in human serum.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3865177      PMCID: PMC391372          DOI: 10.1073/pnas.82.22.7560

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids.

Authors:  A J Berk; P A Sharp
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

2.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

3.  Nucleotide sequence analysis of the leader segments in a cloned copy of adenovirus 2 fiber mRNA.

Authors:  S Zain; J Sambrook; R J Roberts; W Keller; M Fried; A R Dunn
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

4.  Characterization of messenger ribonucleoprotein and messenger RNA from KB cells.

Authors:  A Kumar; U Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-03       Impact factor: 11.205

5.  Biophysical properties of Australia antigen.

Authors:  J L Gerin; R H Purcell; M D Hoggan; P V Holland; R M Chanock
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

6.  In vitro transcription and translation of simian rotavirus SA11 gene products.

Authors:  B B Mason; D Y Graham; M K Estes
Journal:  J Virol       Date:  1980-03       Impact factor: 5.103

7.  Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.

Authors:  G K McMaster; G G Carmichael
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

8.  Polypeptides of hepatitis B virus surface antigen produced by a hepatoma cell line.

Authors:  P L Marion; F H Salazar; J J Alexander; W S Robinson
Journal:  J Virol       Date:  1979-12       Impact factor: 5.103

9.  Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant.

Authors:  K L Berkner; P A Sharp
Journal:  Nucleic Acids Res       Date:  1985-02-11       Impact factor: 16.971

10.  Spliced segments at the 5' terminus of adenovirus 2 late mRNA.

Authors:  S M Berget; C Moore; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1977-08       Impact factor: 11.205

View more
  21 in total

1.  Expression of the F and HN glycoproteins of human parainfluenza virus type 3 by recombinant vaccinia viruses: contributions of the individual proteins to host immunity.

Authors:  M K Spriggs; B R Murphy; G A Prince; R A Olmsted; P L Collins
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

2.  An adenovirus-simian immunodeficiency virus env vaccine elicits humoral, cellular, and mucosal immune responses in rhesus macaques and decreases viral burden following vaginal challenge.

Authors:  S L Buge; E Richardson; S Alipanah; P Markham; S Cheng; N Kalyan; C J Miller; M Lubeck; S Udem; J Eldridge; M Robert-Guroff
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Establishment of a foreign antigen secretion system in mycobacteria.

Authors:  K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; K Terasaka; M Totsuka; K Kobayashi; H Yukitake; T Yamada
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

4.  Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins.

Authors:  John R Mascola; Anna Sambor; Kristin Beaudry; Sampa Santra; Brent Welcher; Mark K Louder; Thomas C Vancott; Yue Huang; Bimal K Chakrabarti; Wing-Pui Kong; Zhi-Yong Yang; Ling Xu; David C Montefiori; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

5.  The adenovirus tripartite leader sequence can alter nuclear and cytoplasmic metabolism of a non-adenovirus mRNA within infected cells.

Authors:  M A Moore; T Shenk
Journal:  Nucleic Acids Res       Date:  1988-03-25       Impact factor: 16.971

6.  A new hamster model for adenoviral vaccination.

Authors:  R N Hjorth; G M Bonde; W A Pierzchala; S K Vernon; F P Wiener; M H Levner; M D Lubeck; P P Hung
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

7.  Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus.

Authors:  M D Lubeck; A R Davis; M Chengalvala; R J Natuk; J E Morin; K Molnar-Kimber; B B Mason; B M Bhat; S Mizutani; P P Hung
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

8.  Distinctive properties of the hepatitis B virus envelope proteins.

Authors:  K L Molnar-Kimber; V Jarocki-Witek; S K Dheer; S K Vernon; A J Conley; A R Davis; P P Hung
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

9.  The Gordon Wilson Lecture: viruses and human disease.

Authors:  G J Nabel
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

10.  Methods for construction of adenovirus vectors.

Authors:  F L Graham; L Prevec
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.